Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The takeover gives Boston Scientific ownership of an FDA-approved endoscopic device that ablates gastrointestinal tissue using radiofrequency waves.
Medeon Biodesign, a Taiwanese maker of minimally invasive surgical devices, sold its large bore vascular closure system to Terumo for $20 million.
Flex is teaming with Google to help healthcare device makers connect the information gathered by devices to Google Cloud.
J&J’s Janssen is transferring a respiratory assay panel and some of the staff who worked on it to Biocartis.
The agreement sees Novartis work with Pear to get a schizophrenia app to market while developing an earlier-stage treatment for multiple sclerosis.
Abbott is paying $25 million upfront and committing to up to $67 million in development milestones to add the device to its vascular disease pipeline.
Biosensorix's new collaboration will give it access to an electrochemical lateral flow immunosensor.
The partners think advanced imaging and software can enable a streamlined, automated workflow suitable for use on a large scale.
Cota, a healthcare data analytics company, will use the funds to advance its Cota Nodal Address disease classification system.
Months after losing its hepatitis C collaboration with Janssen, Achillion is trying to cut costs.